Dermatitis News

Prevalence of prurigo nodularis is higher than previously estimated and is associated with many comorbidities, according to a study.

Alphyn Biologics presented interim data from the second cohort of its phase 2a clinical trial program of AB-101a for the treatment of atopic dermatitis, according to a presentation at the Society for Pediatric Dermatology annual meeting.

Once-daily crisaborole ointment 2% may be an effective and well-tolerated long-term maintenance therapy for pediatric and adult patients with mild to moderate atopic dermatitis, according to a study.

Alphyn Biologics announced new data from its phase 2a clinical trial evaluating topical AB-101a for the treatment of mild to moderate atopic dermatitis in patients aged as young as 2 years, according to a company release.

CHICAGO — Allergists treating atopic dermatitis might consider focusing on the skin microbiome to improve outcomes, according to a presenter at the Global Food Allergy Prevention Summit.

Patients taking lebrikizumab for the treatment of moderate to severe atopic dermatitis maintained similar responses regardless of dose frequency, according to results presented at 25th World Congress of Dermatology in Singapore.

In this Healio video exclusive, George Martin, MD, discusses highlights from Maui Derm NP+PA, including the use of oral and topical JAK inhibitors to treat atopic dermatitis.

The sun is finally shining a little brighter this summer, bringing health benefits and also some potential risks this season.

In a panel-led project, 23 experts created a comprehensive guide for the long-term management of inflammatory skin diseases in pediatric patients treated with methotrexate.

Patients with rosacea, alopecia areata, psoriasis or atopic dermatitis all face an elevated risk for cardiovascular disease, according to a study.